Results 281 to 290 of about 101,847 (315)
Some of the next articles are maybe not open access.
The Unique Role of Fluorodeoxyglucose-PET in Radioembolization
PET Clinics, 2019Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry.
Bastiaannet, Remco +3 more
openaire +4 more sources
Fluorodeoxyglucose-PET in the management of breast cancer
Radiologic Clinics of North America, 2004FDG-PET can be helpful in the diagnosis of primary breast cancer, especially in patients with dense breast tissue, significant fibrocystic changes, fibrosis after radiotherapy, and inconclusive results from MR imaging and other imaging modalities. PET has a limited role in patients with very small tumors and with well-differentiated and lobular types ...
Abass Alavi, Rakesh Kumar
openaire +3 more sources
PET Clinics, 2022
Endocrine neoplasms and malignancies are a diverse group of tumors with varied clinical, histopathologic, and functional features. These tumors vary from sporadic to hereditary, isolated entities to multiple neoplastic syndromes, functioning and non functioning tumors, unifocal locally invasive, and advanced to multifocal tumors with disseminated ...
Aadil, Adnan +3 more
openaire +2 more sources
Endocrine neoplasms and malignancies are a diverse group of tumors with varied clinical, histopathologic, and functional features. These tumors vary from sporadic to hereditary, isolated entities to multiple neoplastic syndromes, functioning and non functioning tumors, unifocal locally invasive, and advanced to multifocal tumors with disseminated ...
Aadil, Adnan +3 more
openaire +2 more sources
Muscle uptake of 18-fluorine fluorodeoxyglucose
Seminars in Nuclear Medicine, 2000F LUORODEOXYGLUCOSE (FDG) is well established as a tumor-seeking agent that is taken up by a wide variety of malignant tumors. Several nonmalignant lesions also are FDG avid, as are normal organ systems that use glucose as part of their metabolism. Low-grade FDG uptake in muscles is part of the normal biodistribution pattern of FDG, especially during ...
Robert C. Stadalnik +2 more
openaire +3 more sources
Fluorodeoxyglucose-PET in Breast Cancer [PDF]
, 2006 Similar to the previously discussed approved applications in oncology, FDGPET in breast cancer has demonstrated superior diagnostic accuracy compared with conventional anatomic imaging for the detection of distant metastases. This increased accuracy in lesion detection has translated into improved staging, especially in cases with a high clinical ...
R. Edward Coleman +2 more
openaire +1 more source
Fluorodeoxyglucose PET in Relapsing Polychondritis
New England Journal of Medicine, 2008The authors report on a case of fever of unknown origin in which 18F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) was instrumental in depicting cartilage inflammation, which eventual...
Frank De Geeter +1 more
openaire +2 more sources
PET Clinics, 2022
Molecular imaging with PET-computerized tomography (PET-CT) plays an important role in oncology. There is current and evolving evidence supporting the use of fluorodeoxyglucose (FDG) and non-FDG tracers in assessment patients with hepatobiliary and pancreatic cancers in various clinical scenarios.
Gopinath, Gnanasegaran +2 more
openaire +2 more sources
Molecular imaging with PET-computerized tomography (PET-CT) plays an important role in oncology. There is current and evolving evidence supporting the use of fluorodeoxyglucose (FDG) and non-FDG tracers in assessment patients with hepatobiliary and pancreatic cancers in various clinical scenarios.
Gopinath, Gnanasegaran +2 more
openaire +2 more sources
Brain fluorodeoxyglucose (FDG) PET in dementia
Ageing Research Reviews, 2016The purpose of this article is to present a selective and concise summary of fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG PET is used to visualize a downstream topographical marker that indicates the distribution of neural injury or synaptic dysfunction, and can identify distinct phenotypes of dementia due to ...
Takashi Kato +3 more
openaire +3 more sources
Fluorodeoxyglucose-PET in the management of malignant melanoma
Radiologic Clinics of North America, 2005FDG-PET is of limited use in patients with early-stage disease without nodal or distant metastases (stage I-II), because sentinel node biopsy is much more sensitive in detecting microscopic lymph node metastases. Because of the high tumor-to-background ratio, FDG-PET can highlight metastases at unusual sites that are easily missed with conventional ...
Gonca Bural +3 more
openaire +3 more sources
[18F]-Fluorodeoxyglucose PET Imaging of Atherosclerosis
PET Clinics, 2015[(18)F]-fluorodeoxyglucose PET ((18)FDG PET) imaging has emerged as a promising tool for assessment of atherosclerosis. By targeting atherosclerotic plaque glycolysis, a marker for plaque inflammation and hypoxia, (18)FDG PET can assess plaque vulnerability and potentially predict risk of atherosclerosis-related disease, such as stroke and myocardial ...
Blomberg, Björn Alexander +1 more
openaire +3 more sources